ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

In Brief: ESMO Names Annual Award Winners

October 10, 2014

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988

World Conference To Consider Smoking Problem, Research, Action

March 14, 1975

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009